Enlivex Reports Initiation Of Dosing In Phase IIb Trial With Allocetra - Quick Facts

Enlivex Therapeutics Ltd. (ENLV) announced the initiation of dosing in its placebo-controlled phase IIb trial evaluating Allocetra in severe and critical COVID-19 patients with acute respiratory distress syndrome. The trial is expected to recruit up to 152 severe COVID-19 patients in clinical centers in Israel and certain European countries. Top-line data are anticipated in the second quarter of 2022.

Enlivex previously reported positive top-line results from phase Ib and phase II investigator-initiated clinical trials of Allocetra in COVID-19 patients in severe and critical condition.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Merck & Co., Inc., known as MSD outside the U.S. and Canada, has recalled one lot of intravenous antibiotic Cubicin (daptomycin for injection) 500 mg for the potential presence of particulate matter identified as glass particles, the U.S. Food and Drug Administration or FDA said in a statement. The National Restaurant Association or NRA shot out a letter to the U.S. Conference of Mayors suggesting that expanded outdoor dining is the need of the hour for the restaurant industry to sustain the winter. The NRA also warned that thousands of restaurants without this facility could close down very soon. The U.S. Food and Drug Administration is investigating a multistate outbreak of Salmonella Oranienburg infections linked to whole, fresh onions. The outbreak has resulted in 652 illnesses in consumers across the U.S. to date. The traceback investigation has identified Hailey, Idaho -based ProSource Inc., also known as ProSource Produce, LLC, as a source.
Follow RTT